Antimicrobial‐Associated Risk Factors for Clostridium difficile Infection

Owens, Jr., Robert C., Donskey, Curtis J., Gaynes, Robert P., Loo, Vivian G., Muto, Carlene A.·2008·Clinical Infectious Diseases
DOI 10.1086/521859

Cited by (603)

Items 301–400 of 603

  1. Predictors of 30-Day Mortality in Hospitalized Patients with Clostridium difficile Infection
    Jayakrishna Chintanaboina, Seyedehsan Navabi, Kristen A. Suchniak-Mussari, Benjamin Stern, Simranjit Bedi, Erik B Lehman, Andrew Tinsley · 2017 · Southern Medical Journal
  2. High rate of Clostridium difficile among young adults presenting with diarrhea at two hospitals in Kenya
    Micah Oyaro, Kimberly Plants-Paris, Dayna E. Bishoff, Paul Malonza, Christopher Gontier, Herbert L. DuPont, Charles Darkoh · 2018 · International Journal of Infectious Diseases
  3. Influencing duration of antibiotic therapy: A behavior change analysis in long-term care
    Bradley J. Langford, Jacquelyn Quirk, Stacie Carey, Nick Daneman, Gary E Garber · 2019 · American Journal of Infection Control
  4. Detection and Genomic Characterisation of Clostridioides difficile from Spinach Fields
    Pilar Marcos, Paul Whyte, Catherine M. Burgess, Daniel Ekhlas, Declan Bolton · 2022 · Pathogens
  5. Excess risk of Clostridium difficile infection in ovarian cancer is related to exposure to broad-spectrum antibiotics
    Josephine S. Kim, Kristy K. Ward, Nina R. Shah, Cheryl C. Saenz, Michael T McHale, Steven Charles Plaxe · 2013 · Supportive Care in Cancer
  6. Impact of different empirical antibiotic treatment regimens for community-acquired pneumonia on the emergence of Clostridium difficile
    Anke H. W. Bruns, Jan Jelrik Oosterheert, Ed J. Kuijper, Jan‐Willem J. Lammers, Steven F. T. Thijsen, Annet Troelstra, Andy I. M. Hoepelman · 2010 · Journal of Antimicrobial Chemotherapy
  7. Origin, genomic diversity and microevolution of the Clostridium difficile B1/NAP1/RT027/ST01 strain in Costa Rica, Chile, Honduras and Mexico
    Enzo Guerrero-Araya, Claudio Meneses, Eduardo Castro‐Nallar, Ana M Guzmán D, Manuel Álvarez-Lobos, Carlos Quesada-Gómez, Daniel Paredes‐Sabja, César Rodríguez · 2020 · Microbial Genomics
  8. Short-course antibiotic regimen compared to conventional antibiotic treatment for gram-positive cocci infective endocarditis: randomized clinical trial (SATIE)
    Carmen Olmos, Isidre Vilacosta, Javier López, Carmen Sáez, Manuel P. Anguita, Pablo Elpidio García-Granja, Cristina Sarriá, Jacobo Silva, Belén Álvarez Álvarez, María Amparo Martínez-Monzonis et al. · 2020 · BMC Infectious Diseases
  9. Outcomes and Risk Factors Associated withClostridium difficileDiarrhea in Hospitalized Adult Patients
    Daniela Zilio Larentis, Régis Goulart Rosa, Rodrigo Pires dos Santos, Luciano Zubaran Goldani · 2015 · Gastroenterology Research and Practice
  10. Levaquin Gets a Pass
    Armin Rashidi, Thomas Kaiser, Shernan G. Holtan, Tauseef Ur Rehman, Daniel Jordan Weisdorf, Alexander Khoruts, Christopher M. Staley · 2019 · Transplantation and Cellular Therapy
  11. Comparison of the clinical efficacy of cefquinome with the combination of penicillin G and gentamicin in equine patients
    Andreas Franz Widmer, M. Kummer, M. Wehrli Eser, Anton Fürst · 2009 · Equine Veterinary Education
  12. Antimicrobial Prophylaxis and Modifications of the Gut Microbiota in Children with Cancer
    Gianluca Bossù, Riccardo Di Sario, Alberto Argentiero, Susanna Esposito · 2021 · Antibiotics
  13. Clostridioides difficile in Pigs and Dairy Cattle in Northern Italy: Prevalence, Characterization and Comparison between Animal and Human Strains
    Patrizia Spigaglia, Fabrizio Barbanti, Silvia Faccini, Mariella Vescovi, Enrico Maria Criscuolo, Rossella Ceruti, Clara Gaspano, Carlo Rosignoli · 2023 · Microorganisms
  14. Clostridium difficile in western Romania: unfavourable outcome predictors in a hospital for infectious diseases
    Ruxandra Laza, Ruxandra Jurac, Alexandru Florian Crișan, Voichița Elena Lăzureanu, Monica Licker, Emilian Damian Popovici, Luminița Bădițoiu · 2015 · BMC Infectious Diseases
  15. Risk Factors for Clostridium Difficile Diarrhea in Patients With Solid Organ Transplantation
    António Ramos, Jorge Ortiz, Ángel Asensio, Rocío Martínez-Ruiz, Elena Múñez, Mireia Cantero, Alberto Cózar-Llistó, Piedad Ussetti, José María Portolés, Valentín Cuervas‐Mons · 2016 · Progress in Transplantation
  16. Factors associated with an outbreak of hospital-onset, healthcare facility-associated Clostridium difficile infection (HO-HCFA CDI) in a Mexican tertiary care hospital: A case-control study
    Eric Ochoa‐Hein, José Sifuentes‐Osornio, Alfredo Ponce‐de‐León, Pedro Torres‐González, Víctor Granados-García, Arturo Galindo‐Fraga · 2018 · PLoS ONE
  17. Systematic Review and Meta-Analysis on the Frequency of Antibiotic-Resistant Clostridium Species in Saudi Arabia
    Saeed Banawas · 2022 · Antibiotics
  18. Nosokomiale Infektionen
    Winfried V. Kern, Markus Dettenkofer · 2009 · Der Internist
  19. The European surveillance activities EARSS and ESAC in the context of ABS International
    Sigrid Metz-Gercek, Helmut Mittermayer · 2008 · Wiener klinische Wochenschrift
  20. Identification of a novel mutation at the primary dimer interface of GyrA conferring fluoroquinolone resistance in Clostridium difficile
    Micheál Mac Aogáin, Shauna Kilkenny, Claire Walsh, Sinéad Lindsay, Geraldine Moloney, Trefor Morris, Sophie C.P. Jones, Thomas Richard Rogers · 2015 · Journal of Global Antimicrobial Resistance
  21. Cohort study of immediate implant exchange during acute infection in the setting of breast reconstruction
    Shailesh Agarwal, Russell E. Ettinger, Theodore A. Kung, Jeffrey H. Kozlow, David L. Brown · 2017 · Journal of Plastic Reconstructive & Aesthetic Surgery
  22. Clostridium difficile toxin B induces autophagic cell death in colonocytes
    Hung Chan, Shan Zhao, Lin Zhang, Jeffery Ho, Czarina C.H. Leung, Wai Tat Wong, Yuanyuan Tian, Xiaodong Liu, Thomas N.Y. Kwong, Raphael C.Y. Chan et al. · 2018 · Journal of Cellular and Molecular Medicine
  23. Challenges for Economic Evaluation of Health Care Strategies to Contain Antimicrobial Resistance
    Emily A. F. Holmes, Dyfrig Arwyn Hughes · 2019 · Antibiotics
  24. Clostridium difficile infection: A critical overview
    Bayan Missaghi, August J. Valenti, Robert C. Owens · 2008 · Current Infectious Disease Reports
  25. Peri‐transplant clostridium difficile infections in patients undergoing allogeneic hematopoietic progenitor cell transplant
    Aya Agha, Alison R. Sehgal, Matthew J. Lim, David Weber, Jing‐Zhou Hou, Rafic Farah, Anastasios Raptis, Annie Im, Kathleen Anne Dorritie, Stanley M. Marks et al. · 2015 · American Journal of Hematology
  26. The metabolic impact of bacterial infection in the gut
    Pooja Chaukimath, Gad M. Frankel, Sandhya Srikant Visweswariah · 2022 · FEBS Journal
  27. Mucosal Vaccination Strategies against Clostridioides difficile Infection
    Joshua Heuler, Harish Chandra, Xingmin Sun · 2023 · Vaccines
  28. Gut microbiota in relationship to diabetes mellitus and its late complications with a focus on diabetic foot syndrome: A review
    Hana Sechovcová, Tiziana Maria Mahayri, Jakub Mrázek, Radka Jarošíková, Jitka Husáková, Veronika Wosková, Vladimı́ra Fejfarová · 2023 · Folia Microbiologica
  29. Omitted doses as an unintended consequence of a hospital restricted antibacterial system: a retrospective observational study
    Neil Powell, Bryony Dean Franklin, Ann Jacklin, Michael Wilcock · 2015 · Journal of Antimicrobial Chemotherapy
  30. Beneficial Effect of Oral Tigecycline Treatment on Clostridium difficile Infection in Gnotobiotic Piglets
    Hyeun Bum Kim, Quanshun Zhang, Xingmin Sun, Gillian Beamer, Yuankai Wang, Saul R. Tzipori · 2014 · Antimicrobial Agents and Chemotherapy
  31. A Detrimental Role of Immunosuppressive Drug, Dexamethasone, During Clostridium difficile Infection in Association with a Gastrointestinal Microbial Shift
    Hyeun Bum Kim, Yuankai Wang, Xingmin Sun · 2016 · Journal of Microbiology and Biotechnology
  32. What Would the Screen-and-Treat Strategy for Helicobacter pylori Mean in Terms of Antibiotic Consumption?
    Mārcis Leja, Uga Dumpis · 2019 · Digestive Diseases and Sciences
  33. Antimicrobial Stewardship and Environmental Decontamination for the Control of Clostridium difficile Transmission in Healthcare Settings
    Jason Bintz, Suzanne Lenhart, Cristina Lanzas · 2016 · Bulletin of Mathematical Biology
  34. The microbial diversity following antibiotic treatment of Clostridioides difficile infection
    Dana Binyamin, Orna Nitzan, Maya Azrad, Zohar Hamo, Omry Koren, Avi Peretz · 2021 · BMC Gastroenterology
  35. Prevalence, Molecular Characterization and Antimicrobial Susceptibility of Clostridioides difficile Isolated from Pig Carcasses and Pork Products in Central Italy
    Caterina Licciardi, Sara Primavilla, Rossana Roila, Alessia Lupattelli, Silvana Farneti, Giuliana Blasi, Annalisa Petruzzelli, Ilenia Drigo, E. Di Raimo Marrocchi · 2021 · International Journal of Environmental Research and Public Health
  36. Infection in the intensive care unit (ICU)
    Rishi H‐P Dhillon, John L. Clark · 2009 · Current Anaesthesia and Critical Care
  37. Clostridium difficile Infection in Humans and Piglets: A ‘One Health’ Opportunity
    Michele M. Squire, Thomas Victor Riley · 2012 · Current topics in microbiology and immunology
  38. Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients
    Karam M. Obeid, Smarika Sapkota, Qing Cao, Steven Richmond, Allison Paige Watson, Fatma Keklik Karadağ, Jo‐Anne H. Young, Timothy L. Pruett, Daniel Jordan Weisdorf, Celalettin Üstün · 2021 · Transplant Infectious Disease
  39. Penicillin Binding Protein Substitutions Cooccur with Fluoroquinolone Resistance in Epidemic Lineages of Multidrug-Resistant Clostridioides difficile
    Kate E. Dingle, Jane Freeman, Xavier Didelot, T. Phuong Quan, David W. Eyre, Jeremy Swann, William D. Spittal, Emma Clark, Keith A. Jolley, Ann Sarah Walker et al. · 2023 · mBio
  40. Clostridioides difficile Infection: Landscape and Microbiome Therapeutics.
    Brent J. Gawey, Sahil Khanna · 2023 · PubMed Central
  41. Risk factors associated with Clostridium difficile infection in kidney transplant recipients
    Michael L. Spinner, Brian R. Stephany, Pooja Cerrato, Simon W. Lam, Elizabeth A. Neuner, Kajal S. Patel · 2018 · Transplant Infectious Disease
  42. Clostridium difficile ribotypes in Austria: a multicenter, hospital-based survey
    on behalf of the Austrian C. difficile Study Group, Alexander Indra, Daniela Schmid, Steliana Huhulescu, Erica Simons, Markus Hell, Karl Stickler, Franz J. Allerberger · 2015 · Wiener klinische Wochenschrift
  43. Use of therapeutic drug monitoring to treat Elizabethkingia meningoseptica meningitis and bacteraemia in an adult
    Elizabeth A. Neuner, Carlotta Ahrens, Joseph J. Groszek, Carlos M. Isada, Michael A. Vogelbaum, William Henry Fissell, Adarsh Bhimraj · 2012 · Journal of Antimicrobial Chemotherapy
  44. Benefits and unintended consequences of antimicrobial de-escalation: Implications for stewardship programs
    Josie S. Hughes, Xi Huo, Lindsey Falk, Amy Hurford, Kunquan Lan, Bryan A. Coburn, Andrew Mark Morris, Jianhong Wu · 2017 · PLoS ONE
  45. Comparison of ceftriaxone plus macrolide and ampicillin/sulbactam plus macrolide in treatment for patients with community-acquired pneumonia without risk factors for aspiration: an open-label, quasi-randomized, controlled trial
    Nobuyoshi Hamao, Isao Ito, Satoshi Konishi, Naoya Tanabe, Masahiro Shirata, Issei Oi, Mitsuhiro Tsukino, Hisako Matsumoto, Yoshiro Yasutomo, Seizo Kadowaki et al. · 2020 · BMC Pulmonary Medicine
  46. Antistaphylococcal Agents
    Howard S. Gold, Satish K. Pillai · 2009 · Infectious Disease Clinics of North America
  47. Detection of antibiotic resistance toxigenic Clostridium difficile in processed retail lettuce
    Yi Han, Joan M. King, Marlene E. Janes · 2018 · Food Quality and Safety
  48. Antimicrobial Stewardship: From Bedside to Theory. Thirteen Examples of Old and More Recent Strategies from Everyday Clinical Practice
    Stefano Di Bella, Bojana Beovič, Massimiliano Fabbiani, Michael Valentini, Roberto Luzzati · 2020 · Antibiotics
  49. Exploring novel microbial metabolites and drugs for inhibiting Clostridioides difficile
    Ahmed Adel Abouelkhair, Mohamed N. Seleem · 2024 · mSphere
  50. Why Does Doxycycline Pose a Relatively Low Risk for Promotion of Clostridioides difficile Infection?
    Dongyan Xu, Thriveen S.C. Mana, Jennifer L. Cadnum, Abhishek Deshpande, Faezeh Afsari, Naseer Sangwan, Curtis J. Donskey · 2022 · Pathogens and Immunity
  51. Upcoming Rules and Benchmarks Concerning the Monitoring of and the Payment for Surgical Infections
    Nitin Sajankila, John J. Como, Jeffrey A. Claridge · 2014 · Surgical Clinics of North America
  52. Impact of Tigecycline Versus Other Antibiotics on the Fecal Metabolome and on Colonization Resistance to Clostridium difficile in Mice
    Robin Jump, David Kraft, Kelly N. Hurless, Alex Polinkovsky, Curtis J. Donskey · 2017 · Pathogens and Immunity
  53. Clostridium difficile infection in the Lao People’s Democratic Republic: first isolation and review of the literature
    Elaine Y. L. Cheong, Tamalee Roberts, Sayaphet Rattanavong, Thomas Victor Riley, Paul N. Newton, David A. B. Dance · 2017 · BMC Infectious Diseases
  54. Prevalence, Antimicrobial Resistance and Toxin-Encoding Genes of Clostridioides difficile from Environmental Sources Contaminated by Feces
    Khald Blau, Claudia Gallert · 2023 · Antibiotics
  55. Community-acquired upper respiratory tract infections and the role of third-generation oral cephalosporins
    JAMES A. HEDRICK · 2009 · Expert Review of Anti-infective Therapy
  56. Treatment of Clostridium difficile infection using SQ641, a capuramycin analogue, increases post-treatment survival and improves clinical measures of disease in a murine model
    John H. Moore, Edward J. van Opstal, Glynis L. Kolling, Jae Hyun Shin, Elena Bogatcheva, B. V. Nikonenko, Leo Einck, Andrew J. Phipps, Richard L. Guerrant, Marina N. Protopopova et al. · 2016 · Journal of Antimicrobial Chemotherapy
  57. Development of 1,2,4-Oxadiazole Antimicrobial Agents to Treat Enteric Pathogens within the Gastrointestinal Tract
    Noel P. Pitcher, Jitendra R. Harjani, Yichao Zhao, Jianwen Jin, Daniel R. Knight, Lucy Li, Papanin Putsathit, Thomas Victor Riley, Glen P. Carter, Jonathan B. Baell · 2022 · ACS Omega
  58. Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe?
    Dominic Crocombe, Alastair J O'Brien · 2023 · Hepatology Communications
  59. Association Between Use of Proton Pump Inhibitors and a Clostridium difficile– Associated Disease Outbreak: Case–Control Study
    Stephanie Linney, Tania Fernandes, Thomas Ray Einarson, Anjana Sengar, John H. Walker, Allan Mills · 2010 · The Canadian Journal of Hospital Pharmacy
  60. Faecal microbiota transplantation: a review of FMT as an alternative treatment forClostridium difficileinfection
    Chris Dowle · 2016 · Bioscience Horizons The International Journal of Student Research
  61. Intestinal Microbiota Composition in Sudden Infant Death Syndrome and Age-Matched Controls
    Lex E. X. Leong, Steven Taylor, Aravind Shivasami, Paul Nathan Goldwater, Geraint B. Rogers · 2017 · The Journal of Pediatrics
  62. Association between Antibiotic Consumption and Incidence of Clostridioides difficile Infection in a Hospital
    Bongyoung Kim, Jieun Kim, Hyunjoo Pai · 2020 · Journal of Korean Medical Science
  63. Semi‐automated risk estimation using large databases: quinolones and clostridium difficile associated diarrhea
    Robertino M. Mera, Kathleen J. Beach, Gregory E. Powell, Edward N. Pattishall · 2010 · Pharmacoepidemiology and Drug Safety
  64. Étude de la sensibilité aux antibiotiques de souches cliniques de Clostridium difficile isolées de 2001 à 2007 au CHU Henri-Mondor, Créteil
    Vincent Cattoir, Zahia Ould-Hocine, P. Legrand · 2008 · Pathologie Biologie
  65. Health Care-Associated Infection Prevention and Control: Pharmacists' Role in Meeting National Patient Safety Goal 7
    Allison V. Tauman, Ari A. Robicsek, Joyce Roberson, John M. Boyce · 2009 · Hospital Pharmacy
  66. Comparison of the intestinal flora of wild and artificial breeding green turtles (Chelonia mydas)
    Xin Niu, Lin Liu, Ting Zhang, Xiaoyu An, Yupei Li, Yangfei Yu, Meiling Hong, Haitao Shi, Ding Li · 2024 · Frontiers in Microbiology
  67. Revisiting the Evidence Base That Informs the Use of Adjunctive Therapy for Enterococcus faecalis Endocarditis: A Systematic Review and Meta-Analysis
    Connor J. Prosty, Mark Sorin, Khaled Katergi, Roy Khalaf, Clare Fogarty, Malick Turenne, Todd Campbell Lee, Emily Gibson McDonald · 2024 · Clinical Infectious Diseases
  68. Guidance on Prevention and Control of Clostridium difficile Infection (CDI) in Healthcare Settings in Scotland
    Scottish Guidance · 2009
  69. Incidence of and risk factors for recurrent Clostridioides difficile infection in Japan using a claims database: A retrospective cohort study
    Hiroshige Mikamo, Takayuki Kondo, Kotoba Okuyama, Stephen W. Marcella, Daniel J. Ruzicka · 2019 · Anaerobe
  70. Update on Clostridioides difficile Infection in Older Adults
    Curtis J. Donskey · 2023 · Clinics in Geriatric Medicine
  71. Comparison of the Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Healthy Japanese and Caucasian Subjects
    Hiroyuki Oshima, Takao Yamazaki, Lauren Benner, Takashi Miki, Ingrid N. Michon, Tomasz Wojtkowski, Atsunori Kaibara, SALIM K. MUJAIS · 2015 · Clinical Drug Investigation
  72. Antimicrobial Prescribing in Hospitalized Adults Stratified by Age
    Peter Zarb, Brice Amadéo, Arno Müller, Nico Drapier, Vanessa Vankerckhoven, Peter G Davey, Herman Goossens · 2011 · Drugs & Aging
  73. Is High Consumption of Antibiotics Associated with Clostridium difficile Polymerase Chain Reaction–Ribotype 027 Infections in France?
    Gabriel Birgand, Katiuska Miliani, A. Carbonne, Pascal Astagneau · 2010 · Infection Control and Hospital Epidemiology
  74. Systems approaches for the clinical diagnosis of Clostridioides difficile infection
    Qinglong Wu, Tor Savidge · 2020 · Translational research
  75. The effects of avoiding extended antimicrobial drain prophylaxis on Clostridioides difficile and postprocedural infection rates: a 5-year retrospective
    Alexandria C. Marino, Evan D. Robinson, Jakob A. Durden, Heather L. Cox, Amy J. Mathers, Mark Edwin Shaffrey · 2022 · Journal of neurosurgery
  76. Advances in Therapeutic Strategies for the Management of Clostridioides difficile Infection
    Antonio Vitiello, Michela Sabbatucci, Andrea Zovi, Antonio Salzano, Annarita Ponzo, Mariarosaria Boccellino · 2024 · Journal of Clinical Medicine
  77. Novel Management Strategies in the Treatment of Severe Clostridium difficile Infection
    Ibrahim Nassour, Evie H. Carchman, Richard L. Simmons, Brian Scott Zuckerbraun · 2012 · Advances in Surgery
  78. A unique strain of community-acquired Clostridium difficile in severe complicated infection and death of a young adult
    Orville D. Heslop, Karen Judith Roye-Green, Kathleen C. M. Coard, Michael R. Mulvey · 2013 · BMC Infectious Diseases
  79. Correlation between hospital-level antibiotic consumption and incident health care facility-onset Clostridium difficile infection
    Page E. Crew, Nathaniel J. Rhodes, J. Nicholas O’Donnell, Cristina M. Miglis, Elise M. Gilbert, Teresa Zembower, Chao Qi, Christina Silkaitis, Sarah H. Sutton, Marc H. Scheetz · 2017 · American Journal of Infection Control
  80. In Vitro Activity of Tedizolid, Dalbavancin, and Ceftobiprole Against Clostridium difficile
    Dana Binyamin, Orna Nitzan, Maya Azrad, Zohar Hamo, Omry Koren, Avi Peretz · 2018 · Frontiers in Microbiology
  81. Incidence of Clostridioides difficile infection (CDI) related to antibiotic prescribing by GP surgeries in Wales
    Florence A. S. Tydeman, Noel Craine, Kimberley Kavanagh, Helen Adams, Rosy Reynolds, Victoria McClure, Harriet C. Hughes, Matthew Hickman, Chris Robertson · 2021 · Journal of Antimicrobial Chemotherapy
  82. Real-World Data in Pharmacovigilance Database Provides a New Perspective for Understanding the Risk of Clostridium difficile Infection Associated with Antibacterial Drug Exposure
    Dongxuan Li, Yi Song, Zhanfeng Bai, Xin Xi, Feng Liu, Yang Zhang, Chunmeng Qin, Dan Du, Qian Du, Songqing Liu · 2023 · Antibiotics
  83. Clostridium difficile infection in the elderly.
    Stefano Di Bella, Alessandro Capone, Maria Musso, Maddalena Giannella, Agapito Tarasi, Emma Johnson, Fabrizio Taglietti, Caterina Campoli, Nicola Petrosillo · 2013 · PubMed
  84. Male veterans with complicated urinary tract infections: Influence of a patient-centered antimicrobial stewardship program
    James F. Carbo, Christine A. Ruh, Kari E. Kurtzhalts, Michael C. Ott, John A. Sellick, Kari A. Mergenhagen · 2016 · American Journal of Infection Control
  85. Prevalence, characteristics and antimicrobial susceptibility patterns of Clostridioides difficile isolated from hospitals in Iran
    Mojtaba Alimolaei, Hamid Reza Rahimi, Majid Ezatkhah, Mehrdad Shamsaddini Bafti, Sadegh Afzali · 2019 · Journal of Global Antimicrobial Resistance
  86. Inpatient fluoroquinolone use in Veterans’ Affairs hospitals is a predictor of Clostridioides difficile infection due to fluoroquinolone-resistant ribotype 027 strains
    Sandra Y. Silva, Brigid M. Wilson, Sarah N. Redmond, Curtis J. Donskey · 2020 · Infection Control and Hospital Epidemiology
  87. Efecto de la infección por Clostridium difficile sobre la estancia hospitalaria. Estudio de cohortes
    Diana Monge Martín, Isabel Millán, Alba González-Escalada, Ángel Asensio · 2013 · Enfermedades Infecciosas y Microbiología Clínica
  88. Tigecycline exhibits inhibitory activity against Clostridium difficile in the intestinal tract of hospitalised patients
    Sirisha Kundrapu, Kelly N. Hurless, Venkata C. K. Sunkesula, Myreen E. Tomas, Curtis J. Donskey · 2015 · International Journal of Antimicrobial Agents
  89. The risk of prescribing antibiotics “just-in-case” there is infection
    Debra A. Goff, Thomas M. File · 2017 · Seminars in Colon and Rectal Surgery
  90. Effects of dietary supplementation of formaldehyde and crystalline amino acids on gut microbial composition of nursery pigs
    Hayden E Williams, R. A. Cochrane, Jason C Woodworth, Joel M DeRouchey, Steven S Dritz, Mike D Tokach, Cassandra K Jones, Samodha C. Fernando, Thomas E. Burkey, Y. S. Li et al. · 2018 · Scientific Reports
  91. Evaluation of a successful fluoroquinolone restriction intervention among high-risk patients: A mixed-methods study
    Jessica S Tischendorf, Matthew Brunner, Mary Jo Knobloch, Lucas T. Schulz, Anna Barker, Marc‐Oliver Wright, Alexander J. Lepak, Nasia Safdar · 2020 · PLoS ONE
  92. Trends in Clostridioides difficile infection across a public health hospital system in New York City 2019-2021: A cautionary note
    Anna Maro, Habtamu Asrat, Wenqi Qiu, Rina Liang, Subin Sunny, Saif Aslam, Marie Abdallah, Mary L. Fornek, Briana Episcopia, John M. Quale · 2022 · American Journal of Infection Control
  93. Towards a mathematical understanding of invasion resistance in multispecies communities
    Erida Gjini, Sten Madec · 2023 · Royal Society Open Science
  94. Antimicrobial susceptibility of Clostridium difficile isolated from animals and humans in Brazil
    Rodrigo Otávio Silveira Silva, Carlos Augusto Oliveira, Amanda Nádia Diniz, Guilherme Guerra Alves, Roberto Maurício Carvalho Guedes, Eduardo García Vilela, Francisco Carlos Faria Lobato · 2014 · Ciência Rural
  95. Factors Affecting Treatment and Recurrence of Clostridium difficile Infections
    Kazuaki Matsumoto, Naoko Kanazawa, Akari Shigemi, Kazuro Ikawa, Norifumi Morikawa, Toyoyasu Koriyama, Michiyo Orita, Hideki Kawamura, Koichi Tokuda, Junichiro Nishi et al. · 2014 · Biological and Pharmaceutical Bulletin
  96. Pharmacokinetics–pharmacodynamics, computer decision support technologies, and antimicrobial stewardship: the compass and rudder
    Robert C. Owens, Catharine C. Bulik, David R. Andes · 2018 · Diagnostic Microbiology and Infectious Disease
  97. Clostridioides difficile Infection in Kidney Transplant Recipients
    UZhe Ding, Lijin Ooi, Henry H. L. Wu, Rajkumar Chinnadurai · 2024 · Pathogens
  98. Analysis of ESAC-Net/EARS-Net Data from 29 EEA Countries for Spatiotemporal Associations Between Antimicrobial Use and Resistance—Implications for Antimicrobial Stewardship?
    James Charles McSorley · 2025 · Antibiotics
  99. Evaluation of the US Food and Drug Administration sentinel analysis tools in confirming previously observed drug‐outcome associations: The case of clindamycin and Clostridium difficile infection
    Ryan M. Carnahan, Jennifer L. Kuntz, Shirley V. Wang, Candace C. Fuller, Joshua J. Gagne, Charles E. Leonard, Sean Hennessy, Tamra E. Meyer, Patrick Archdeacon, Chih‐Ying Chen et al. · 2018 · Pharmacoepidemiology and Drug Safety
  100. Fecal microbiota live – jslm (Rebyota™/RBL) for management of recurrent Clostridioides difficile infection
    Bethany L Boyle, Sahil Khanna · 2024 · Future Microbiology